CENTURY THERAPEUTICS INC (IPSC) Stock Income Statement
NASDAQ:IPSC - Nasdaq - US15673T1007 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 6.59M | 2.23M | 5.20M | 0.00 | 0.00 | |||
| Operating Expenses | 140.40M | 127.42M | 129.03M | 94.88M | 49.18M | |||
| Research and Development | 107.24M | 92.71M | 97.17M | 75.65M | 39.68M | |||
| Selling, General, and Administrative Expenses | 33.16M | 34.71M | 31.86M | 19.24M | 9.50M | |||
| Operating Income | -133.81M | -125.18M | -123.83M | -94.88M | -49.18M | |||
| Interest Income/Expense | 13.01M | 12.14M | -1.43M | -1.28M | -380.00K | |||
| Other Income/Expense | 354.00K | -383.00K | 4.42M | 380.00K | 700.00K | |||
| Non Recurring Items | -4.33M | -21.36M | -10.00M | 0.00 | -4.72M | |||
| Income Before Taxes | -124.78M | -134.79M | -130.84M | -95.78M | -53.58M | |||
| Income Tax | 1.79M | 1.88M | 90.00K | 40.00K | N/A | |||
| Net Income | -126.57M | -136.67M | -130.93M | -95.82M | -53.58M | |||
| EBITDA | -120.51M | -112.14M | -115.39M | -91.13M | -47.78M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.61 | -2.30 | -2.27 | -2.96 | -7.16 | |||
| Non GAAP EPS | -1.63 | -2.29 | -2.28 | N/A | N/A | |||
| Statistics | ||||||||
| Profit Margin | -1920.87% | -6115.12% | -2517.88% | N/A | N/A | |||
| Operating Profit Margin | -2030.81% | -5600.94% | -2381.35% | N/A | N/A | |||
All data in USD